Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.8 GBX | -0.37% | +3.64% | -7.53% |
Apr. 12 | JPMorgan raises Taylor Wimpey, Persimmon | AN |
Mar. 12 | Target Healthcare interim net asset value and contractual rent grow | AN |
Sales 2024 * | 71.4M 89.57M | Sales 2025 * | 73.17M 91.79M | Capitalization | 495M 621M |
---|---|---|---|---|---|
Net income 2024 * | 64M 80.29M | Net income 2025 * | 65M 81.54M | EV / Sales 2024 * | 10.2 x |
Net Debt 2024 * | 231M 290M | Net Debt 2025 * | 256M 321M | EV / Sales 2025 * | 10.3 x |
P/E ratio 2024 * |
7.6
x | P/E ratio 2025 * |
7.58
x | Employees | - |
Yield 2024 * |
7.14% | Yield 2025 * |
7.31% | Free-Float | 99.9% |
1 day | -0.37% | ||
1 week | +3.64% | ||
Current month | +2.57% | ||
1 month | -0.75% | ||
3 months | -2.68% | ||
6 months | -2.92% | ||
Current year | -7.53% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | - | |
Gordon Bland
DFI | Director of Finance/CFO | 45 | - |
John Flannelly
CIO | Chief Investment Officer | 49 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Vince Niblett
BRD | Director/Board Member | - | 21-08-24 |
Richard Cotton
BRD | Director/Board Member | 68 | 22-10-31 |
Michael Brodtman
BRD | Director/Board Member | 64 | 22-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 79.8 | -0.37% | 1,134,541 |
24-05-02 | 80.1 | +2.04% | 692,589 |
24-05-01 | 78.5 | +0.90% | 359,424 |
24-04-30 | 77.8 | -0.38% | 1,263,060 |
24-04-29 | 78.1 | +1.43% | 873,885 |
Delayed Quote London S.E., May 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.53% | 621M | |
+2.99% | 27.38B | |
+7.77% | 24.98B | |
+0.82% | 21.07B | |
+0.96% | 16.07B | |
-1.09% | 15.52B | |
-0.56% | 13.1B | |
-0.16% | 12.59B | |
-10.22% | 11.81B | |
+5.92% | 11.44B |
- Stock Market
- Equities
- THRL Stock